106 related articles for article (PubMed ID: 18075300)
1. SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.
Amir S; Mabjeesh NJ
Cancer Biol Ther; 2007 Dec; 6(12):1926-31. PubMed ID: 18075300
[TBL] [Abstract][Full Text] [Related]
2. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
Amir S; Golan M; Mabjeesh NJ
Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
[TBL] [Abstract][Full Text] [Related]
3. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
Amir S; Wang R; Simons JW; Mabjeesh NJ
J Biol Chem; 2009 Apr; 284(17):11142-51. PubMed ID: 19251694
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.
Gonzalez ME; Makarova O; Peterson EA; Privette LM; Petty EM
Cell Signal; 2009 Apr; 21(4):477-87. PubMed ID: 19071215
[TBL] [Abstract][Full Text] [Related]
5. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
[TBL] [Abstract][Full Text] [Related]
6. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
Vardi-Oknin D; Golan M; Mabjeesh NJ
PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
[TBL] [Abstract][Full Text] [Related]
7. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
Tazat K; Schindler S; Depping R; Mabjeesh NJ
Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
[TBL] [Abstract][Full Text] [Related]
8. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
Golan M; Mabjeesh NJ
Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
[TBL] [Abstract][Full Text] [Related]
9. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
Golan M; Mabjeesh NJ
Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
[TBL] [Abstract][Full Text] [Related]
10. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
[TBL] [Abstract][Full Text] [Related]
11. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.
Escuin D; Kline ER; Giannakakou P
Cancer Res; 2005 Oct; 65(19):9021-8. PubMed ID: 16204076
[TBL] [Abstract][Full Text] [Related]
12. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
[TBL] [Abstract][Full Text] [Related]
13. Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
Chacko AD; McDade SS; Chanduloy S; Church SW; Kennedy R; Price J; Hall PA; Russell SE
Cell Oncol (Dordr); 2012 Apr; 35(2):85-93. PubMed ID: 22278362
[TBL] [Abstract][Full Text] [Related]
14. Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.
Sellin ME; Stenmark S; Gullberg M
Mol Biol Cell; 2012 Nov; 23(21):4242-55. PubMed ID: 22956766
[TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of Neuronal Nitric Oxide Synthase Expression by Cobalt Chloride Through a HIF-1α Mechanism in Neuroblastoma Cells.
Li G; Zhao Y; Li Y; Lu J
Neuromolecular Med; 2015 Dec; 17(4):443-53. PubMed ID: 26458913
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions.
Zeng L; Kizaka-Kondoh S; Itasaka S; Xie X; Inoue M; Tanimoto K; Shibuya K; Hiraoka M
Cancer Sci; 2007 Sep; 98(9):1394-401. PubMed ID: 17608771
[TBL] [Abstract][Full Text] [Related]
17. Properties of SEPT9 isoforms and the requirement for GTP binding.
Robertson C; Church SW; Nagar HA; Price J; Hall PA; Russell SE
J Pathol; 2004 May; 203(1):519-27. PubMed ID: 15095474
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region.
Raspaglio G; Filippetti F; Prislei S; Penci R; De Maria I; Cicchillitti L; Mozzetti S; Scambia G; Ferlini C
Gene; 2008 Feb; 409(1-2):100-8. PubMed ID: 18178340
[TBL] [Abstract][Full Text] [Related]
19. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
Koga F; Tsutsumi S; Neckers LM
Cell Cycle; 2007 Jun; 6(11):1393-402. PubMed ID: 17525527
[TBL] [Abstract][Full Text] [Related]
20. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.
Amir S; Wang R; Matzkin H; Simons JW; Mabjeesh NJ
Cancer Res; 2006 Jan; 66(2):856-66. PubMed ID: 16424018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
